Showing results (11-20 of 315) with videos related to
Sort By:
Pageof 32
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 16, 2024
Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytesClaudia Mittendorff, Issam Abu-Taha, Lena Kassler, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 29, 2009
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug targetDobromir DobrevNaunyn-Schmiedeberg'S Archives of Pharmacology|November 14, 2007
Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?Dobromir DobrevJournal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|March 12, 2008
New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillationDobromir DobrevHerzschrittmachertherapie & Elektrophysiologie|December 8, 2017
Ion channels as part of macromolecular multiprotein complexes : Clinical significanceJordi Heijman, Dobromir DobrevNature Reviews. Cardiology|August 5, 2016
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillationStanley Nattel, Dobromir DobrevLancet (London, England)|March 26, 2010
New antiarrhythmic drugs for treatment of atrial fibrillationDobromir Dobrev, Stanley NattelEuropace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 30, 2012
Cellular and molecular correlates of ectopic activity in patients with atrial fibrillationNiels Voigt, Dobromir DobrevJournal of Molecular and Cellular Cardiology|October 29, 2017
Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use?Eleonora Grandi, Dobromir DobrevPageof 32